Influenza

[1]  S. Klug,et al.  [Vaccination against influenza: International inventory and perspectives for Germany]. , 2021, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[2]  C. Boikos,et al.  Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017–2018 and 2018–2019 Influenz , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  R. Dorey,et al.  Influenza vaccination: protecting the most vulnerable , 2021, European Respiratory Review.

[4]  M. Terhardt,et al.  Beschluss und Wissenschaftliche Begründung der Ständigen Impfkommission (STIKO) für die Aktualisierung der Influenza-Impfempfehlung für Personen im Alter von ≥ 60 Jahren , 2020 .

[5]  U. Ochmann,et al.  Impfschutz für medizinisches Personal* , 2020, InFo Hämatologie + Onkologie.

[6]  Christopher L. Cummings,et al.  A typology of beliefs and misperceptions about the influenza disease and vaccine among older adults in Singapore , 2020, PloS one.

[7]  U. Ochmann.  Impfschutz für medizinisches Personal , 2020, CME.

[8]  L. Haynes,et al.  Diminished immune responses with aging predispose older adults to common and uncommon influenza complications. , 2019, Cellular immunology.

[9]  Joe J. Senn,et al.  mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials. , 2019, Vaccine.

[10]  D. Matysiak-Klose,et al.  [Compliance with adult measles and pertussis vaccination recommendations : Analysis of data from the national monitoring system KV-Impfsurveillance]. , 2019, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[11]  P. S. Leventhal,et al.  Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis , 2019, Expert review of vaccines.

[12]  C. Betsch,et al.  [Psychological antecedents of vaccination: definitions, measurement, and interventions]. , 2019, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[13]  Christine Nardini,et al.  Vaccination in the elderly: The challenge of immune changes with aging. , 2018, Seminars in immunology.

[14]  I. Barr,et al.  Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness , 2018, npj Vaccines.

[15]  W. Schaffner,et al.  Seasonal influenza immunisation: Strategies for older adults , 2018, International journal of clinical practice.

[16]  M. Taljaard,et al.  Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial. , 2017, The Lancet. Respiratory medicine.

[17]  A. Neumann,et al.  Age dependent differences in the kinetics of γδ T cells after influenza vaccination , 2017, PloS one.

[18]  Cornelia Betsch,et al.  Barriers of Influenza Vaccination Intention and Behavior – A Systematic Review of Influenza Vaccine Hesitancy, 2005 – 2016 , 2017, PloS one.

[19]  A. Domnich,et al.  Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis. , 2017, Vaccine.

[20]  Rachael M. Jones,et al.  Occupational exposures to influenza among healthcare workers in the United States , 2016, Journal of occupational and environmental hygiene.

[21]  O. Wichmann,et al.  [Implementation of the influenza vaccination recommendation in nursing homes in Germany : results of a survey as part of the national influenza immunization campaign]. , 2014, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[22]  Manon M J Cox,et al.  FluBlok, a next generation influenza vaccine manufactured in insect cells. , 2009, Biologicals : journal of the International Association of Biological Standardization.

[23]  T. Murphy,et al.  Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. , 2007, JAMA.

[24]  K. Nichol,et al.  The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. , 2003, Vaccine.